|
|||||
|
|
| Daunorubicin,cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety,tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study | |
| 引用本文： | Ho?owiecki J,Grosicki S,Kyrcz-Krzemien S,Skotnicki AB,Piatkowska-Jakubas B,Warzocha K,Seferynska I,Zdziarska B.Daunorubicin,cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety,tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study[J].Annals of Hematology,2008,87(5):361-367. |
| 作者姓名： | Ho?owiecki J Grosicki S Kyrcz-Krzemien S Skotnicki AB Piatkowska-Jakubas B Warzocha K Seferynska I Zdziarska B |
| 摘 要： | |
| 收稿时间： | 22 July 2007 |
| 修稿时间： | 20 November 2007 |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |